COMMUNIQUÉS West-GlobeNewswire

Ofatumumab Demonstrates Superiority Versus Teriflunomide in Two Head-to-Head Phase III Multiple Sclerosis Studies
30/08/2019
Company Announcement In ASCLEPIOS I and II, ofatumumab (OMB157) met primary endpoints to reduce the annualized relapse rate (ARR) over teriflunomide in patients with relapsing forms of multiple sclerosis (RMS) Key [...]
Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies
30/08/2019
In ASCLEPIOS I and II, ofatumumab (OMB157) met primary endpoints to reduce the annualized relapse rate over Aubagio ®* (teriflunomide) in patients with relapsing forms of MS (RMS)[1] Key secondary endpoints of delaying [...]
Media Advisory - Save Your Skin Launches Inaugural “Move For Melanoma” Challenge Benefiting Skin Cancer Patients Across Canada
30/08/2019
The unique physical activity challenge takes place across Canada from September 13-16 VANCOUVER, British Columbia, Aug. 30, 2019 (GLOBE NEWSWIRE) -- On Friday, September 13 th Save Your Skin Foundation will officially [...]
ObsEva SA to Participate in Upcoming Investor Conferences
30/08/2019
Geneva, Switzerland and Boston, MA – August 30, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Bone Therapeutics reports half year 2019 results
30/08/2019
Regulated information The interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial instruments admitted to trading on a regulated market and can [...]
Bone Therapeutics publie ses résultats du premier semestre 2019
30/08/2019
Information réglementée Le rapport semestriel est préparé conformément à l’article 13 de l’Arrêté Royal relatif aux obligations des émetteurs d’instruments financiers admis à la négociation sur un marché réglementé et [...]
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
30/08/2019
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
MediciNova to Attend the Morgan Stanley Global Healthcare Conference in New York
30/08/2019
LA JOLLA, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Mesoblast Reports 2019 Full Year Results
29/08/2019
Strong Operational Progress and Continued Growth in Revenues from Royalties NEW YORK and MELBOURNE, Australia, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported strong [...]
Medcolcanna Organics Inc. Announces Financial Results for Second Quarter of 2019
29/08/2019
BOGOTA, Colombia, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc. (the “ Company ” or “ Medcolcanna ”) (TSXV: MCCN) announces the filing of its financial and operating results for the three and six months [...]
Ascendis Pharma A/S Announces Three Investor Presentations in September
29/08/2019
COPENHAGEN, Denmark, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced [...]
Achillion to Present at the Baird 2019 Global Healthcare Conference
29/08/2019
BLUE BELL, Pa., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by [...]
Xeris Pharmaceuticals to Present at Two September Healthcare Conferences
29/08/2019
CHICAGO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use [...]
Catalyst Biosciences Announces Transition of Chief Financial Officer
29/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that its chief financial officer, Fletcher Payne, will be stepping down from the Company to [...]
MacroGenics to Participate in Upcoming Investor Conferences
29/08/2019
ROCKVILLE, MD, Aug. 29, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
CooperCompanies Announces Third Quarter 2019 Results
29/08/2019
PLEASANTON, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for the fiscal third quarter ended July 31, 2019. Revenue increased 3% year-over-year to $679.4 million [...]
Synthorx to Present at H.C. Wainwright 21st Annual Global Investment Conference
29/08/2019
SAN DIEGO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today announced the Company will [...]
Agios to Present at the Citi 14th Annual Biotech Conference on Thursday, September 5, 2019
29/08/2019
CAMBRIDGE, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is [...]
Menlo Therapeutics to Present at the HC Wainwright 21st Annual Global Investment Conference
29/08/2019
REDWOOD CITY, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]

Pages